Aegerion Pharmaceuticals, Inc.

This study monitored 11 patients with generalized lipodystrophy, a rare disorder causing severe fat loss and metabolic problems, who were starting daily metreleptin injections. The main goal was to see if their immune systems developed antibodies against the drug over three years…